aluates Reports

$ 0.0

Automative

Global HER-2 Targeted Drugs for Breast Cancer Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-3T6275

Global HER 2 Targeted Drugs for Breast Cancer Market Insights and Forecast to 2028

BUY CHAPTERS

Global HER-2 Targeted Drugs for Breast Cancer Market Research Report 2025

Code: QYRE-Auto-3T6275

Report

September 2025

Pages:72

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Roche

Chugai Pharmaceutical

GlaxoSmithKline PLC

Novartis

Pfizer Inc

CANbridge

Puma Biotechnology

Hengrui Medicine

Beacon Pharmaceuticals Limited

Hetero Drugs

HER-2 Targeted Drugs for Breast Cancer Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

HER-2 Targeted Drugs for Breast Cancer Market

The global market for HER-2 Targeted Drugs for Breast Cancer was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for HER-2 Targeted Drugs for Breast Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HER-2 Targeted Drugs for Breast Cancer.

The HER-2 Targeted Drugs for Breast Cancer market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global HER-2 Targeted Drugs for Breast Cancer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the HER-2 Targeted Drugs for Breast Cancer companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of HER-2 Targeted Drugs for Breast Cancer Market Report

Report Metric	Details
Report Name	HER-2 Targeted Drugs for Breast Cancer Market
CAGR	5%
Segment by Type	Trastuzumab Pertuzumab Lapatinib Neratinib Trastuzumab Emtansine Pyrotinib Others
Segment by Application	Hospital Clinic Drug Center Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche, Chugai Pharmaceutical, GlaxoSmithKline, Novartis, Pfizer, CANbridge, Puma Biotechnology, Hengrui Medicine, Beacon Pharmaceuticals Limited, Hetero Drugs
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of HER-2 Targeted Drugs for Breast Cancer company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the HER-2 Targeted Drugs for Breast Cancer Market report?

Ans: The main players in the HER-2 Targeted Drugs for Breast Cancer Market are Roche, Chugai Pharmaceutical, GlaxoSmithKline, Novartis, Pfizer, CANbridge, Puma Biotechnology, Hengrui Medicine, Beacon Pharmaceuticals Limited, Hetero Drugs

What are the Application segmentation covered in the HER-2 Targeted Drugs for Breast Cancer Market report?

Ans: The Applications covered in the HER-2 Targeted Drugs for Breast Cancer Market report are Hospital, Clinic, Drug Center, Others

What are the Type segmentation covered in the HER-2 Targeted Drugs for Breast Cancer Market report?

Ans: The Types covered in the HER-2 Targeted Drugs for Breast Cancer Market report are Trastuzumab, Pertuzumab, Lapatinib, Neratinib, Trastuzumab Emtansine, Pyrotinib, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global HER-2 Targeted Drugs for Breast Cancer Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Trastuzumab

1.2.3 Pertuzumab

1.2.4 Lapatinib

1.2.5 Neratinib

1.2.6 Trastuzumab Emtansine

1.2.7 Pyrotinib

1.2.8 Others

1.3 Market by Application

1.3.1 Global HER-2 Targeted Drugs for Breast Cancer Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Drug Center

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global HER-2 Targeted Drugs for Breast Cancer Market Perspective (2020-2031)

2.2 Global HER-2 Targeted Drugs for Breast Cancer Growth Trends by Region

2.2.1 Global HER-2 Targeted Drugs for Breast Cancer Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 HER-2 Targeted Drugs for Breast Cancer Historic Market Size by Region (2020-2025)

2.2.3 HER-2 Targeted Drugs for Breast Cancer Forecasted Market Size by Region (2026-2031)

2.3 HER-2 Targeted Drugs for Breast Cancer Market Dynamics

2.3.1 HER-2 Targeted Drugs for Breast Cancer Industry Trends

2.3.2 HER-2 Targeted Drugs for Breast Cancer Market Drivers

2.3.3 HER-2 Targeted Drugs for Breast Cancer Market Challenges

2.3.4 HER-2 Targeted Drugs for Breast Cancer Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top HER-2 Targeted Drugs for Breast Cancer Players by Revenue

3.1.1 Global Top HER-2 Targeted Drugs for Breast Cancer Players by Revenue (2020-2025)

3.1.2 Global HER-2 Targeted Drugs for Breast Cancer Revenue Market Share by Players (2020-2025)

3.2 Global HER-2 Targeted Drugs for Breast Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by HER-2 Targeted Drugs for Breast Cancer Revenue

3.4 Global HER-2 Targeted Drugs for Breast Cancer Market Concentration Ratio

3.4.1 Global HER-2 Targeted Drugs for Breast Cancer Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by HER-2 Targeted Drugs for Breast Cancer Revenue in 2024

3.5 Global Key Players of HER-2 Targeted Drugs for Breast Cancer Head office and Area Served

3.6 Global Key Players of HER-2 Targeted Drugs for Breast Cancer, Product and Application

3.7 Global Key Players of HER-2 Targeted Drugs for Breast Cancer, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 HER-2 Targeted Drugs for Breast Cancer Breakdown Data by Type

4.1 Global HER-2 Targeted Drugs for Breast Cancer Historic Market Size by Type (2020-2025)

4.2 Global HER-2 Targeted Drugs for Breast Cancer Forecasted Market Size by Type (2026-2031)

5 HER-2 Targeted Drugs for Breast Cancer Breakdown Data by Application

5.1 Global HER-2 Targeted Drugs for Breast Cancer Historic Market Size by Application (2020-2025)

5.2 Global HER-2 Targeted Drugs for Breast Cancer Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America HER-2 Targeted Drugs for Breast Cancer Market Size (2020-2031)

6.2 North America HER-2 Targeted Drugs for Breast Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2020-2025)

6.4 North America HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe HER-2 Targeted Drugs for Breast Cancer Market Size (2020-2031)

7.2 Europe HER-2 Targeted Drugs for Breast Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2020-2025)

7.4 Europe HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Size (2020-2031)

8.2 Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Size by Region (2020-2025)

8.4 Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America HER-2 Targeted Drugs for Breast Cancer Market Size (2020-2031)

9.2 Latin America HER-2 Targeted Drugs for Breast Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2020-2025)

9.4 Latin America HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size (2020-2031)

10.2 Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2020-2025)

10.4 Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Roche

11.1.1 Roche Company Details

11.1.2 Roche Business Overview

11.1.3 Roche HER-2 Targeted Drugs for Breast Cancer Introduction

11.1.4 Roche Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2020-2025)

11.1.5 Roche Recent Development

11.2 Chugai Pharmaceutical

11.2.1 Chugai Pharmaceutical Company Details

11.2.2 Chugai Pharmaceutical Business Overview

11.2.3 Chugai Pharmaceutical HER-2 Targeted Drugs for Breast Cancer Introduction

11.2.4 Chugai Pharmaceutical Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2020-2025)

11.2.5 Chugai Pharmaceutical Recent Development

11.3 GlaxoSmithKline

11.3.1 GlaxoSmithKline Company Details

11.3.2 GlaxoSmithKline Business Overview

11.3.3 GlaxoSmithKline HER-2 Targeted Drugs for Breast Cancer Introduction

11.3.4 GlaxoSmithKline Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2020-2025)

11.3.5 GlaxoSmithKline Recent Development

11.4 Novartis

11.4.1 Novartis Company Details

11.4.2 Novartis Business Overview

11.4.3 Novartis HER-2 Targeted Drugs for Breast Cancer Introduction

11.4.4 Novartis Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2020-2025)

11.4.5 Novartis Recent Development

11.5 Pfizer

11.5.1 Pfizer Company Details

11.5.2 Pfizer Business Overview

11.5.3 Pfizer HER-2 Targeted Drugs for Breast Cancer Introduction

11.5.4 Pfizer Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2020-2025)

11.5.5 Pfizer Recent Development

11.6 CANbridge

11.6.1 CANbridge Company Details

11.6.2 CANbridge Business Overview

11.6.3 CANbridge HER-2 Targeted Drugs for Breast Cancer Introduction

11.6.4 CANbridge Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2020-2025)

11.6.5 CANbridge Recent Development

11.7 Puma Biotechnology

11.7.1 Puma Biotechnology Company Details

11.7.2 Puma Biotechnology Business Overview

11.7.3 Puma Biotechnology HER-2 Targeted Drugs for Breast Cancer Introduction

11.7.4 Puma Biotechnology Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2020-2025)

11.7.5 Puma Biotechnology Recent Development

11.8 Hengrui Medicine

11.8.1 Hengrui Medicine Company Details

11.8.2 Hengrui Medicine Business Overview

11.8.3 Hengrui Medicine HER-2 Targeted Drugs for Breast Cancer Introduction

11.8.4 Hengrui Medicine Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2020-2025)

11.8.5 Hengrui Medicine Recent Development

11.9 Beacon Pharmaceuticals Limited

11.9.1 Beacon Pharmaceuticals Limited Company Details

11.9.2 Beacon Pharmaceuticals Limited Business Overview

11.9.3 Beacon Pharmaceuticals Limited HER-2 Targeted Drugs for Breast Cancer Introduction

11.9.4 Beacon Pharmaceuticals Limited Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2020-2025)

11.9.5 Beacon Pharmaceuticals Limited Recent Development

11.10 Hetero Drugs

11.10.1 Hetero Drugs Company Details

11.10.2 Hetero Drugs Business Overview

11.10.3 Hetero Drugs HER-2 Targeted Drugs for Breast Cancer Introduction

11.10.4 Hetero Drugs Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2020-2025)

11.10.5 Hetero Drugs Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Roche

Chugai Pharmaceutical

GlaxoSmithKline PLC

Novartis

Pfizer Inc

CANbridge

Puma Biotechnology

Hengrui Medicine

Beacon Pharmaceuticals Limited

Hetero Drugs

List of Tables

Table 1. Global HER-2 Targeted Drugs for Breast Cancer Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Trastuzumab

Table 3. Key Players of Pertuzumab

Table 4. Key Players of Lapatinib

Table 5. Key Players of Neratinib

Table 6. Key Players of Trastuzumab Emtansine

Table 7. Key Players of Pyrotinib

Table 8. Key Players of Others

Table 9. Global HER-2 Targeted Drugs for Breast Cancer Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 10. Global HER-2 Targeted Drugs for Breast Cancer Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 11. Global HER-2 Targeted Drugs for Breast Cancer Market Size by Region (2020-2025) & (US$ Million)

Table 12. Global HER-2 Targeted Drugs for Breast Cancer Market Share by Region (2020-2025)

Table 13. Global HER-2 Targeted Drugs for Breast Cancer Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 14. Global HER-2 Targeted Drugs for Breast Cancer Market Share by Region (2026-2031)

Table 15. HER-2 Targeted Drugs for Breast Cancer Market Trends

Table 16. HER-2 Targeted Drugs for Breast Cancer Market Drivers

Table 17. HER-2 Targeted Drugs for Breast Cancer Market Challenges

Table 18. HER-2 Targeted Drugs for Breast Cancer Market Restraints

Table 19. Global HER-2 Targeted Drugs for Breast Cancer Revenue by Players (2020-2025) & (US$ Million)

Table 20. Global HER-2 Targeted Drugs for Breast Cancer Market Share by Players (2020-2025)

Table 21. Global Top HER-2 Targeted Drugs for Breast Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HER-2 Targeted Drugs for Breast Cancer as of 2024)

Table 22. Ranking of Global Top HER-2 Targeted Drugs for Breast Cancer Companies by Revenue (US$ Million) in 2024

Table 23. Global 5 Largest Players Market Share by HER-2 Targeted Drugs for Breast Cancer Revenue (CR5 and HHI) & (2020-2025)

Table 24. Global Key Players of HER-2 Targeted Drugs for Breast Cancer, Headquarters and Area Served

Table 25. Global Key Players of HER-2 Targeted Drugs for Breast Cancer, Product and Application

Table 26. Global Key Players of HER-2 Targeted Drugs for Breast Cancer, Date of Enter into This Industry

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global HER-2 Targeted Drugs for Breast Cancer Market Size by Type (2020-2025) & (US$ Million)

Table 29. Global HER-2 Targeted Drugs for Breast Cancer Revenue Market Share by Type (2020-2025)

Table 30. Global HER-2 Targeted Drugs for Breast Cancer Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 31. Global HER-2 Targeted Drugs for Breast Cancer Revenue Market Share by Type (2026-2031)

Table 32. Global HER-2 Targeted Drugs for Breast Cancer Market Size by Application (2020-2025) & (US$ Million)

Table 33. Global HER-2 Targeted Drugs for Breast Cancer Revenue Market Share by Application (2020-2025)

Table 34. Global HER-2 Targeted Drugs for Breast Cancer Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 35. Global HER-2 Targeted Drugs for Breast Cancer Revenue Market Share by Application (2026-2031)

Table 36. North America HER-2 Targeted Drugs for Breast Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. North America HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2020-2025) & (US$ Million)

Table 38. North America HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2026-2031) & (US$ Million)

Table 39. Europe HER-2 Targeted Drugs for Breast Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 40. Europe HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2020-2025) & (US$ Million)

Table 41. Europe HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2026-2031) & (US$ Million)

Table 42. Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 43. Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Size by Region (2020-2025) & (US$ Million)

Table 44. Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Size by Region (2026-2031) & (US$ Million)

Table 45. Latin America HER-2 Targeted Drugs for Breast Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Latin America HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2020-2025) & (US$ Million)

Table 47. Latin America HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2026-2031) & (US$ Million)

Table 48. Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 49. Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2020-2025) & (US$ Million)

Table 50. Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2026-2031) & (US$ Million)

Table 51. Roche Company Details

Table 52. Roche Business Overview

Table 53. Roche HER-2 Targeted Drugs for Breast Cancer Product

Table 54. Roche Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2020-2025) & (US$ Million)

Table 55. Roche Recent Development

Table 56. Chugai Pharmaceutical Company Details

Table 57. Chugai Pharmaceutical Business Overview

Table 58. Chugai Pharmaceutical HER-2 Targeted Drugs for Breast Cancer Product

Table 59. Chugai Pharmaceutical Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2020-2025) & (US$ Million)

Table 60. Chugai Pharmaceutical Recent Development

Table 61. GlaxoSmithKline Company Details

Table 62. GlaxoSmithKline Business Overview

Table 63. GlaxoSmithKline HER-2 Targeted Drugs for Breast Cancer Product

Table 64. GlaxoSmithKline Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2020-2025) & (US$ Million)

Table 65. GlaxoSmithKline Recent Development

Table 66. Novartis Company Details

Table 67. Novartis Business Overview

Table 68. Novartis HER-2 Targeted Drugs for Breast Cancer Product

Table 69. Novartis Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2020-2025) & (US$ Million)

Table 70. Novartis Recent Development

Table 71. Pfizer Company Details

Table 72. Pfizer Business Overview

Table 73. Pfizer HER-2 Targeted Drugs for Breast Cancer Product

Table 74. Pfizer Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2020-2025) & (US$ Million)

Table 75. Pfizer Recent Development

Table 76. CANbridge Company Details

Table 77. CANbridge Business Overview

Table 78. CANbridge HER-2 Targeted Drugs for Breast Cancer Product

Table 79. CANbridge Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2020-2025) & (US$ Million)

Table 80. CANbridge Recent Development

Table 81. Puma Biotechnology Company Details

Table 82. Puma Biotechnology Business Overview

Table 83. Puma Biotechnology HER-2 Targeted Drugs for Breast Cancer Product

Table 84. Puma Biotechnology Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2020-2025) & (US$ Million)

Table 85. Puma Biotechnology Recent Development

Table 86. Hengrui Medicine Company Details

Table 87. Hengrui Medicine Business Overview

Table 88. Hengrui Medicine HER-2 Targeted Drugs for Breast Cancer Product

Table 89. Hengrui Medicine Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2020-2025) & (US$ Million)

Table 90. Hengrui Medicine Recent Development

Table 91. Beacon Pharmaceuticals Limited Company Details

Table 92. Beacon Pharmaceuticals Limited Business Overview

Table 93. Beacon Pharmaceuticals Limited HER-2 Targeted Drugs for Breast Cancer Product

Table 94. Beacon Pharmaceuticals Limited Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2020-2025) & (US$ Million)

Table 95. Beacon Pharmaceuticals Limited Recent Development

Table 96. Hetero Drugs Company Details

Table 97. Hetero Drugs Business Overview

Table 98. Hetero Drugs HER-2 Targeted Drugs for Breast Cancer Product

Table 99. Hetero Drugs Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2020-2025) & (US$ Million)

Table 100. Hetero Drugs Recent Development

Table 101. Research Programs/Design for This Report

Table 102. Key Data Information from Secondary Sources

Table 103. Key Data Information from Primary Sources

Table 104. Authors List of This Report

List of Figures

Figure 1. HER-2 Targeted Drugs for Breast Cancer Picture

Figure 2. Global HER-2 Targeted Drugs for Breast Cancer Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global HER-2 Targeted Drugs for Breast Cancer Market Share by Type: 2024 VS 2031

Figure 4. Trastuzumab Features

Figure 5. Pertuzumab Features

Figure 6. Lapatinib Features

Figure 7. Neratinib Features

Figure 8. Trastuzumab Emtansine Features

Figure 9. Pyrotinib Features

Figure 10. Others Features

Figure 11. Global HER-2 Targeted Drugs for Breast Cancer Market Size by Application (2020-2031) & (US$ Million)

Figure 12. Global HER-2 Targeted Drugs for Breast Cancer Market Share by Application: 2024 VS 2031

Figure 13. Hospital Case Studies

Figure 14. Clinic Case Studies

Figure 15. Drug Center Case Studies

Figure 16. Others Case Studies

Figure 17. HER-2 Targeted Drugs for Breast Cancer Report Years Considered

Figure 18. Global HER-2 Targeted Drugs for Breast Cancer Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 19. Global HER-2 Targeted Drugs for Breast Cancer Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 20. Global HER-2 Targeted Drugs for Breast Cancer Market Share by Region: 2024 VS 2031

Figure 21. Global HER-2 Targeted Drugs for Breast Cancer Market Share by Players in 2024

Figure 22. Global Top HER-2 Targeted Drugs for Breast Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HER-2 Targeted Drugs for Breast Cancer as of 2024)

Figure 23. The Top 10 and 5 Players Market Share by HER-2 Targeted Drugs for Breast Cancer Revenue in 2024

Figure 24. North America HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. North America HER-2 Targeted Drugs for Breast Cancer Market Share by Country (2020-2031)

Figure 26. United States HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Canada HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Europe HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Europe HER-2 Targeted Drugs for Breast Cancer Market Share by Country (2020-2031)

Figure 30. Germany HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. France HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. U.K. HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Italy HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Russia HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Nordic Countries HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Share by Region (2020-2031)

Figure 38. China HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Japan HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. South Korea HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Southeast Asia HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. India HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Australia HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Latin America HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Latin America HER-2 Targeted Drugs for Breast Cancer Market Share by Country (2020-2031)

Figure 46. Mexico HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Brazil HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Share by Country (2020-2031)

Figure 50. Turkey HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. UAE HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. Roche Revenue Growth Rate in HER-2 Targeted Drugs for Breast Cancer Business (2020-2025)

Figure 54. Chugai Pharmaceutical Revenue Growth Rate in HER-2 Targeted Drugs for Breast Cancer Business (2020-2025)

Figure 55. GlaxoSmithKline Revenue Growth Rate in HER-2 Targeted Drugs for Breast Cancer Business (2020-2025)

Figure 56. Novartis Revenue Growth Rate in HER-2 Targeted Drugs for Breast Cancer Business (2020-2025)

Figure 57. Pfizer Revenue Growth Rate in HER-2 Targeted Drugs for Breast Cancer Business (2020-2025)

Figure 58. CANbridge Revenue Growth Rate in HER-2 Targeted Drugs for Breast Cancer Business (2020-2025)

Figure 59. Puma Biotechnology Revenue Growth Rate in HER-2 Targeted Drugs for Breast Cancer Business (2020-2025)

Figure 60. Hengrui Medicine Revenue Growth Rate in HER-2 Targeted Drugs for Breast Cancer Business (2020-2025)

Figure 61. Beacon Pharmaceuticals Limited Revenue Growth Rate in HER-2 Targeted Drugs for Breast Cancer Business (2020-2025)

Figure 62. Hetero Drugs Revenue Growth Rate in HER-2 Targeted Drugs for Breast Cancer Business (2020-2025)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

HER 2 Negative Breast Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Targeted Drugs for Breast Cancer Market Research Report 2024

Drugs for HR HER2 Advanced Breast Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global ER Targeted Drugs for Breast Cancer Market Research Report 2024

Global VEGF Targeted Drugs for Breast Cancer Market Research Report 2024

Breast Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Endocrine Therapy Drugs for Breast Cancer Market Research Report 2024

Breast Cancer Generic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Targeted Drugs for NSCLC Market Research Report 2024

Global Gynecological Cancers Drug Market Research Report 2025

Cancer Therapeutics and Biotherapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Woman Disease Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Estrogen Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Menopause Hormonal Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Menopause Hormonal Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cancers Immunotherapy Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Oncology Anti cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Novel Drug Delivery Systems for Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Personalized Medicine for Cancer Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions